[ad_1]
COVID-19 vaccine candidate developed by China’s WestVac Biopharma Co., Ltd. has acquired a nod from the Nepali authorities to conduct third-phase medical trials within the South Asian nation, the Nepali authorities officers mentioned, Pattern reviews citing Xinhua.
“We authorised the proposal of WestVac Biopharma Co., Ltd. to conduct third-phase trials for its COVID-19 vaccine candidate final month after it submitted all the required paperwork,” Namita Ghimire from the Nepal Well being Analysis Council (NHRC) informed Xinhua on Saturday. “The trials shall be performed amongst individuals aged 18 and above.”
It’s the second China-made vaccine and the third COVID-19 vaccine total to be approved for late-stage medical trials in Nepal.
[ad_2]
Source link